Rocket Pharmaceuticals, Inc.
RCKT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001281895
In the last 90 days, Rocket Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 7 sales; 180 institutions reported holding it in 13F filings for Q2 2026, worth $340.9M in total; Maverick Capital is the only superinvestor holding it.
Q4 2025 vs. Q3 2025
How the institutions holding Rocket Pharmaceuticals, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 173 | 186 | +13 |
| Shares | 96.6M | 91.3M | −5.33M (−5.5%) |
| Value | $314.8M | $320.0M | +$5.25M (+1.7%) |
New holders (31)
Institutions that held Rocket Pharmaceuticals, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
Sold out (18)
Institutions that held Rocket Pharmaceuticals, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Voss Capital, LLC | 300,000 | $978.0K |
| MYDA Advisors LLC | 100,000 | $326.0K |
| Man Group plc | 62,576 | $204.0K |
| Macquarie Group Ltd | 58,000 | $189.0K |
| Erste Asset Management GmbH | 44,700 | $146.6K |
| Thrivent Financial for Lutherans | 35,817 | $117.0K |
| Mitsubishi UFJ Kokusai Asset Management Co., Ltd. | 34,532 | $112.6K |
| Sanders Morris Harris LLC | 27,709 | $90.3K |
| Capstone Investment Advisors, LLC | 14,496 | $47.3K |
| Virtu Financial LLC | 12,386 | $40.0K |
| Pallas Capital Advisors LLC | 11,321 | $36.9K |
| PFG Investments, LLC | 10,700 | $34.9K |
| JustInvest LLC | 10,418 | $34.0K |
| Prudential Financial Inc | 10,260 | $33.4K |
| Botty Investors LLC | 10,000 | $32.6K |
| Advisory Services Network, LLC | 1,000 | $3.26K |
| Principal Securities, Inc. | 42 | $137 |
| Wealthspire Advisors, LLC | 20 | $66 |